CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CYSLTR1 | Cysteinyl leukotriene receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F2R | Coagulation factor II (thrombin) receptor | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
F2RL1 | Coagulation factor II (thrombin) receptor-like 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
FZD10 | Frizzled class receptor 10 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FZD2 | Frizzled class receptor 2 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FZD3 | Frizzled class receptor 3 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
FZD4 | Frizzled class receptor 4 | CD markers Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FZD5 | Frizzled class receptor 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FZD6 | Frizzled class receptor 6 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Mixed |
FZD8 | Frizzled class receptor 8 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GABBR1 | Gamma-aminobutyric acid (GABA) B receptor, 1 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GALR2 | Galanin receptor 2 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GHSR | Growth hormone secretagogue receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPBAR1 | G protein-coupled bile acid receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPER1 | G protein-coupled estrogen receptor 1 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
GPR1 | G protein-coupled receptor 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR101 | G protein-coupled receptor 101 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
GPR110 | G protein-coupled receptor 110 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GPR111 | G protein-coupled receptor 111 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR113 | G protein-coupled receptor 113 | G-protein coupled receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR114 | G protein-coupled receptor 114 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR115 | G protein-coupled receptor 115 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR12 | G protein-coupled receptor 12 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR124 | G protein-coupled receptor 124 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPR125 | G protein-coupled receptor 125 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |